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Disruptions to neuronal mRNA translation are hy-
pothesized to underlie human neurodevelopmental
syndromes. Notably, the mRNA translation re-initia-
tion factor DENR is a regulator of eukaryotic trans-
lation and cell growth, but its mammalian functions
are unknown. Here, we report that Denr influences
the migration of murine cerebral cortical neurons
in vivo with its binding partner Mcts1, whereas per-
turbations to Denr impair the long-term positioning,
dendritic arborization, and dendritic spine charac-
teristics of postnatal projection neurons. We char-
acterized de novo missense mutations in DENR
(p.C37Y and p.P121L) detected in two unrelated hu-
man subjects diagnosed with brain developmental
disorder to find that each variant impairs the func-
tion of DENR in mRNA translation re-initiation and
disrupts the migration and terminal branching of
cortical neurons in different ways. Thus, our findings
link human brain disorders to impaired mRNA trans-
lation re-initiation through perturbations in DENR
(OMIM: 604550) function in neurons.
INTRODUCTION
Over the course of mammalian brain development, new neurons
are generated from local progenitor zones and undergo migra-
tion before settling in their appropriate positions and forming
functional circuits. Key to this process is the regulation of
mRNA translation and intracellular protein synthesis in order
for neurons to respond to environmental guidance cues forThis is an open access article unddirectional cell migration, axon outgrowth, dendritic arborization,
and synaptic connectivity (Barnes and Polleux, 2009; Holt and
Schuman, 2013). Defects in these early steps of neurodevelop-
ment can result in the abnormal placement of neurons, impaired
development of neural connections, and dysregulated synaptic
signaling. Such impairments to nervous system development
are increasingly recognized as important underlying causes of
pediatric neurological conditions, such as epilepsy, intellectual
disability, and autism spectrum disorder (Barkovich et al.,
2005, 2012; Kelleher and Bear, 2008; Stoner et al., 2014; Wegiel
et al., 2010). How exactly translational control contributes to
specific aspects of neurodevelopment and disease remains
poorly understood.
In eukaryotic cells, the translation of cellular mRNAs, normally
bearing a 50 cap structure (m7G) and a 30poly(A) tail, occurs
through a canonical process of initiation, elongation, termination,
and ribosomal recycling (Hinnebusch and Lorsch, 2012). The
importance for canonical mRNA translation in human neuronal
development is reflected by the finding that genetic mutations
in translation factors, such as eIF2g and eIF2B, cause X-linked
intellectual disability and leukoencephalopathy (a neurological
disorder with vanishing white matter), respectively (Borck
et al., 2012; Bugiani et al., 2010; Li et al., 2004). However, there
are several non-canonical mechanisms for translation initiation
of viral mRNAs in eukaryotic cells that do not bear a 50 cap or
possess neither a 50 cap nor a 30poly(A) tail (Firth and Brierley,
2012; Skabkin et al., 2010; Zinoviev et al., 2015). The translation
of such mRNA types involves the functions of several eukaryotic
proteins, such as the density regulated protein, known as DENR,
and its obligate binding partner MCTS1 (Skabkin et al., 2010; Zi-
noviev et al., 2015). DENR is known to play important roles during
mammalian translation, in the processes of ribosome recycling,
in initiation on some viral mRNAs (Skabkin et al., 2010), and
in termination-dependent re-initiation after long open readingCell Reports 15, 1–15, June 7, 2016 ª 2016 The Author(s) 1
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also recently reported that DENR regulates mRNA translation
during Drosophila development through a mechanism involving
translation re-initiation after a ‘‘strong upstream open reading
frame’’ (stuORF) sequence (Schleich et al., 2014). However,
despite recent findings for its requirement in Drosophila devel-
opment (Schleich et al., 2014) as well as a recent study impli-
cating its role in the control of circadian rhythms in mouse cells
(Janich et al., 2015), the functions of DENR in mammalian
neuronal development remain unknown.
In this study, we demonstrate a critical role for DENR in the
development of cerebral cortical neurons. We performed a se-
ries of in utero electroporation experiments in mice and found
that disruptions to Denr impair the migration of neurons within
the embryonic cerebral cortex, and this is dependent on the
interaction of DENR with its binding partner MCTS1. We find
that perturbations to DENR disrupt the long-term positioning of
cortical projection neurons within the postnatal mouse cerebral
cortex, aswell as their terminal differentiation and dendritic spine
density and morphology. In addition, we have characterized de
novo missense mutations to DENR in two unrelated human sub-
jects diagnosed with autism spectrum disorder. We find that
substitution mutations to DENR impair its radial migration func-
tions in vivo. Furthermore, we demonstrate that the presence
of DENR substitutions is detrimental to the development and
synaptic connectivity of cerebral cortical neurons. Our cell-
based reporter assays additionally demonstrate that these sub-
stitution mutations disrupt mRNA translation initiation in different
ways. Taken together, our studies highlight a critical function for
DENR in neuronal development and suggest that DENR substi-
tution mutations may be a causative factor for brain develop-
mental disorder in humans.
RESULTS
Denr Promotes Cell Migration within the Developing
Mouse Cerebral Cortex through Mcts1
Recent functional studies inDrosophila identified Denr as a regu-
lator of mRNA translation and tissue morphogenesis (Schleich
et al., 2014). In humans, a de novo missense (c.110G > A) muta-
tion resulting in a p.C37Y substitution to DENRwas identified in a
patient diagnosed with autism spectrum disorder (Neale et al.,
2012), a neurodevelopmental disorder that is associated with
disruptions to cortical neuron positioning, dendritogenesis, and
synaptogenesis (Barkovich et al., 2005, 2012; Kelleher and
Bear, 2008; Stoner et al., 2014; Wegiel et al., 2010). To search
for additional DENR mutations in patients with an autism-related
diagnosis, we conducted whole-exome sequencing of a patient
diagnosed with Asperger syndrome and associated epilepsy to
identify a de novo missense (c.362C > T, NM_003677) mutation
that results in a p.P121L substitution (Table S1). No other de
novo mutations were identified in the exome. Structural MRI
studies of this individual revealed bilateral frontal periventricular
nodal heterotopia, a hallmark of neuronal migration disorder
(Barkovich et al., 2005, 2012). A search of publically available
genomic databases (including Exome Aggregation Consortium
[ExAC] version 0.3) revealed that the p.C37Y and p.P121L sub-
stitution variants are not present in the general human popula-2 Cell Reports 15, 1–15, June 7, 2016tion, and neither substitution mutation has previously been impli-
cated in human disease (data not shown). Thus, disruptions to
DENR could lead to disorders of neuronal development.
Denr requires its binding partner Mcts1 to exert its effects on
mRNA translation (Schleich et al., 2014; Skabkin et al., 2010),
and so we investigated the expression of both Denr and Mcts1
during mammalian neuronal development at the protein and
mRNA level. In humans,DENR andMCTS1mRNAs are detected
in fetal, newborn, and adult brain (Figures S1A and S1B; Forrest
et al., 2014). In mice, Denr and Mcts1 are detected throughout
mousebrain development through to young adulthood (postnatal
day 30 [P30]), with Denr protein levels increasing with brain age,
whereas a peak inMcts1 protein levels was observed at P10 (Fig-
ure 1A). Immunofluorescence staining of the embryonic mouse
embryonic day 14.5 (E14.5) cerebral cortex revealed prominent
Denr immunoreactivity in cells of the germinal ventricular zone
(VZ), as well as in newborn neurons of the intermediate zone
(IZ) and cortical plate (CP), which co-label with the early postmi-
totic marker bIII-tubulin (TUJ1; Figures 1B and 1C). We analyzed
the immunofluorescence signal within immature neurons at
higher magnification to find that DENR is localized within the
cytoplasm, including the leading process of CP neurons that un-
dergo radial migration (Nadarajah et al., 2002, 2003; Noctor et al.,
2004; Figures 1C’ and 1C’’). Consistent with this pattern of
cellular distribution, we cloned anexpression construct encoding
FLAG epitope-tagged DENR and transduced CP neurons by
electroporation andobserved prominent immunoreactivitywithin
the cytoplasm and leading process (Figure 1D). To demonstrate
DENR expression in cortical neurons within the postnatal cortex,
we performed in utero electroporation to label E14.5-born neu-
rons with GFP expression and then carried out immunostaining
of electroporated brains harvested at P17 when neurons have
completed their migration (Figure 1E). In addition to DENR immu-
noreactivity detected in GFP-labeled neurons, co-labeling
studies with MCTS1 antibody revealed prominent localization
of both fluorescence signals. We performed co-immunoprecipi-
tation studies with postnatal mouse brain lysate to confirm that
DENR interacts with MCTS1 in vivo (Figure 1F). Thus, DENR
and MCTS1 interact in murine cortical neurons and could play a
role in neuronal development within the cerebral cortex.
Next, we performed in utero electroporation studies to deter-
mine whether DENR is important for the development of embry-
onic cortical neurons.WeelectroporatedE14.5-born cortical cells
with a bicistronic vector comprising a GFP expression cassette
together with a Denr targeting short hairpin RNA (shRNA), which
silences Denr expression in mouse Neuro2A cells (Figures 2A
and 2B). We then analyzed the distribution of GFP-labeled cells
within the brains of E14.5-electroporated embryos harvested
3 days later (at E17.5) to find that treatment with Denr shRNA
resulted in a significant disruption of cortical cell migration
compared to treatment with a control shRNA (Figures 2C and
2D). Treatment with Denr shRNA did not lead to a significant
change in cortical progenitor proliferation as judged by immuno-
labeling for the mitosis marker pH3 (Figures S2A and S2B;
p = 0.385 unpaired t test two-tailed; n = 6 control and 5 Denr
shRNA-treated brains per condition) or their specification as
apical progenitors or basal progenitors, as judged by co-labeling
with Pax6 (Figure S2C) and Tbr2, respectively (Figure S2D). We
Figure 1. Denr and Mcts1 Expression during Mouse Brain Development
(A) Immunoblotting reveals DENR andMCTS1 protein signal in mouse brain lysates collected from E14.5, E17.5, P0, P10, P17, and young adult (P30) brain tissue.
qRT-PCR confirmed Denr and Mcts1 mRNA expression surveyed from E11.5 through to P30 (a.u.; expression relative to Pgk1).
(B) Immunofluorescence studies with a DENR antibody reveal a signal throughout cells of the ventricular zone (VZ) and cortical plate (CP). DENR (red) immu-
noreactivity was also coincident with neurons labeled with the neuronal marker TUJ1 (green).
(C) High-magnification images (C’ and C’’) reveal co-localization of DENR and TUJ1 in the perinuclear cytoplasm (arrowheads) as well as the leading process of
CP neurons (arrows).
(D) Immunolabeling studies of E14.5-born, GFP-labeled CP neurons within the E17.5 cortex, which overexpress FLAG-DENR, reveal its predominantly cyto-
plasmic distribution, including their leading process.
(E) Immunostaining reveals DENR (red) and MCTS1 (blue) co-localization in GFP-labeled cortical neurons within layer II–IV of the P17 mouse cortex following
electroporation at E14.5.
(F) DENRwas co-immunoprecipitated with anMCTS1 antibody in studies with neonatal P0 mouse brain lysate. A reciprocal experiment with DENR antibody also
leads to co-immunoprecipitation ofMCTS1. Control immunoprecipitationswere performedwith preimmunized sera. Input lanes for DENR (detected from 20 mg of
lysate) and MCTS1 expression in brain lysate were used in both immunoprecipitation experiments. MCTS1 signals were obtained by immunoprecipitation using
goat anti-MCTS1 antibody from 2 mg total protein in brain lysate.
Graphs plot mean ± SEM. The scale bars represent (B) 100 mm, (C’’) 12.5 mm, (D’) 7.5 mm, and (E) 40 mm.
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observed comparable migration impairment (Figures S2E–S2G),
suggesting that the radial migration functions for Denr are con-
centrationsensitive. In support of this notion,we found that forced
expression ofmouseDenr (Denrwild-type [WT]) also impaired the
migration of E14.5-derived cortical cells within the embryonic
E17.5 cortex, indicative of a dominant, concentration-sensitive
role. In parallel, we adopted a similar approach to find that over-
expressionof humanDENR (DENRWT), in thepresenceofendog-enous levels of mouse Denr expression, also impaired radial
migration (Figures 2C and 2D). Neither knockdown of endoge-
nous Denr nor forced expression of mouse Denr or human
DENR led to precocious gliogenesis (immunostaining for glial
fibrillary acidic protein [GFAP]) or excessive programmed cell
death (visualized via immunostaining for thepro-apoptoticmarker
activated-caspase 3; Figures S2H and S2I), thus ruling out these
factors as potential confounds. To further validate the specificity
of Denr shRNA knockdown on cell migration, we performed aCell Reports 15, 1–15, June 7, 2016 3
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porated with mouse Denr WT, which is refractory to RNAi (Fig-
ure S2J). We found that the defective migration of Denr shRNA-
treated cells was restored to levels resembling control treatment
when co-treated with Denr WT (see Figures S2K and S2L;
F(4,30) = 16; p < 0.001; two-way ANOVA). Similarly, the defective
migration of Denr shRNA-treated cells could also be ameliorated
by co-treatment of human DENRWT, which is refractory to RNAi
(Figures 2E, 2F, S2G, and S2M). Of note, we found that themigra-
tion profile ofDenr shRNA-treated cells rescuedwithmouseDenr
WT was not significantly different to cells rescued with human
DENR WT (Figure S2N; F(2,21) = 0.95; p = 0.403; two-way
ANOVA). Thus, we find that appropriate levels of Denr are impor-
tant for radial migration within the embryonic cortex, and mouse
and human DENR are functionally equivalent in our in vivo assay
for cortical neuron development.
We wanted to determine whether Denr required Mcts1 to pro-
mote cell migration in vivo. Using Mcts1 small interfering RNAs
(siRNAs) (Figure S2O), we found that knockdown of Mcts1 dis-
rupted the capacity for DENRWT to restore the defective migra-
tion of Denr shRNA-treated cells, because the profile of Denr
shRNA + DENR WT +Mcts1 siRNA-treated cells was not signif-
icantly different to Denr shRNA treatment (Figures 2E and 2F). In
a reciprocal experiment, we found that the defective migration
of DENR-overexpressing cells was abrogated upon co-delivery
of Mcts1 siRNA (Figures 2G and 2H), again suggesting that
MCTS1 is an obligate partner to DENR in radial migration. How-
ever, knockdown of Mcts1 alone does not disrupt migration,
suggesting that remnant MCTS1 is likely sufficient for migration
(Figures S2P and S2Q), whereas Denr disruption is sensitive to
concurrentMcts1 knockdown by siRNAs in our migration assay.
Also, the defective migration of Denr shRNA-treated cells is not
exacerbated by co-treatment with Mcts1 siRNAs (Figures S2R
and S2S). Therefore, our data demonstrate that Denr and
Mcts1 coordinate radial migration within the embryonic cortex.
Perturbations to Denr Expression Impair the Long-Term
Positioning and Terminal Differentiation of Cerebral
Cortical Neurons
Given thatDenr immunoreactivity is prominent in projection neu-
rons of the postnatal mouse cerebral cortex (Figure 1E), weFigure 2. DENR Regulates Cell Migration in Concert with MCTS1
(A) qRT-PCR analysis of Neuro2A cells transiently transfected with either a co
significant decrease in Denr mRNA levels.
(B) Parallel immunoblotting studies show depletion of Denr protein levels upon D
(C) In utero electroporation studies of E14.5-labeled cortical cells within the E1
GFP-only vector), Denr shRNA (together with GFP-only vector), and forced expres
GFP expression vector comprising a DENR expression cassette).
(D) Denr knockdown as well as overexpression of mouse or human DENR result
cortices (control 0.426 ± 0.045; Denr shRNA 0.287 ± 0.039; Denr WT 0.231 ± 0.0
Bonferroni multiple comparison test; *p < 0.05; n = 3–5).
(E and F) The defective migration of Denr shRNA-treated cells can be restored
co-treatment with Mcts1 siRNAs abolishes this effect (Denr shRNA 0.287 ± 0.03
siRNA 0.334 ± 0.042; two-way ANOVA F(2,30) = 2.897; p = 0.0386 with Bonferro
(G and H)Whereas forced expression of DENRWT disrupts cell migration, co-deli
the proportion of GFP+ cells that arrive within CP (two-way ANOVA F(2,30) = 14.12
siRNAs 0.525 ± 0.056; Bonferroni multiple comparison test; ***p < 0.005; n = 6), tog
(DENR WT + control siRNA 0.453 ± 0.018 versus DENR WT + Mcts1 siRNA 0.31
Graphs plot mean ± SEM. The scale bars represent (C) 25 mm and (E and G) 50extended our studies to investigate whether disruptions to
Denr might affect the long-term positioning of E14.5-born neu-
rons within the brains of treated mice harvested at P17, a time
point by which their migration has concluded. We observed a
significant interaction between the layer distribution of GFP+
neurons and DENR disruption (Figures 3A and 3B; two-way
ANOVA F(8,80) = 1.095; p = 0.3754). Notably, knockdown of
endogenousDenr led to a significant decrease in the proportions
of GFP+ neurons in layers II–IV, together with a concomitant in-
crease in neurons in layers V and VI. Forced expression of DENR
WT did not significantly disrupt long-term positioning, despite
the presence of scattered GFP+ cells in deeper layers (Fig-
ure S3A). We confirmed that these disruptions to Denr did not
alter the expression of the neuronal fate specification marker
CUX1 in GFP+ cells (Figure S3B). Thus, DENR is critical to the
positioning of neurons within the postnatal cortex, but not their
specification as cortical projection neurons.
To investigate whether DENR is important for the terminal dif-
ferentiation of post-migratory neurons, we analyzed the dendritic
morphology and dendritic spines properties of layer II/III cortical
neurons following knockdown of endogenous Denr or overex-
pression of DENR. We combined GFP confocal microscopy
with 3D image reconstruction to obtain images of GFP-labeled
neurons and then performed Sholl analysis as a quantitative rep-
resentation of the dendritic branching of neurons measured with
increasing distance from the cell soma (Ngo et al., 2014). Our re-
sults show that both knockdown and overexpression led to
increased dendritic complexity of neurons proximal (30–50 mm)
to the cell body (Figures 3C, 3D, and S3C–S3E), but the numbers
of primary neurites as well as their branch points were not signif-
icantly different across conditions (Figure 3E).
Given the association between DENR mutations and autism
spectrum disorder, a neurodevelopmental condition that is
correlated with functional deficits in synaptic signaling (Chen
et al., 2015), we analyzed dendritic spine density and spine mor-
phologies of neurons in the context of Denr perturbations by
combining high-power confocal microscopy with digital image
reconstruction and morphometric analysis (Ngo et al., 2014;
see Experimental Procedures). We performed separate analyses
on apical and basal dendrites because it is known that both have
different signaling properties and dendritic spine characteristicsntrol (non-targeting) shRNA construct or Denr shRNA construct revealed a
enr shRNA treatment.
7.5 cortex following treatment with control (non-targeting shRNA vector with
sion of mouse Denr WT or human DENRWT (non-targeting shRNA vector with
ed in a significant reduction in the proportion of GFP+ cells in the CP of E17.5
28; DENR WT 0.324 ± 0.027; two-way ANOVA F(4,33) = 3.980; p < 0.0096 with
by co-delivery of human DENR WT, which is refractory to knockdown, but
9; Denr shRNA + DENR WT 0.435 ± 0.036; Denr shRNA + DENR WT + Mcts1
ni multiple comparison test; *p < 0.05; n = 3–5).
very ofMcts1 siRNAs abolishes this effect, observed as a significant increase in
; p < 0.0001; DENRWT + control siRNA 0.299 ± 0.02 versus DENRWT +Mcts1
ether with a concomitant reduction in the proportion of GFP+ cells within the IZ
7 ± 0.04; Bonferroni multiple comparison test; *p < 0.05).
mm.
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Figure 3. The Effects of Knockdown and Overexpression of DENR on the Long-Term Positioning and Dendritic Morphology of Postnatal
Cortical Projection Neurons
(A) Fluorescence immunostaining on coronal sections to study the positioning of GFP-labeled cells within the P17 postnatal cortex following in utero electro-
poration at E14.5.
(B) Treatment with Denr shRNAs, but not DENRWT, led to a significant interaction in the positioning of neurons within the P17 cortex (two-way ANOVA F(8,80) =
1.095; p = 0.03754; n = 5–7), with only knockdown ofDenr resulting in a significantly reduced proportion of GFP-positive cells in layers II–IV compared with control
(control 0.984 ± 0.008; Denr shRNA 0.965 ± 0.007; DENR WT 0.968 ± 0.0153; *p < 0.05).
(C) Representative confocal microscopy images of GFP-labeled, layer II/III cortical projection neurons from each condition.
(D) Sholl analysis reveals differences in the branching complexity of neurons between conditions, with significant alterations in branching detected 30–50 mm from
the cell body (see also Figures S3C–S3E).
(E) Treatment with Denr shRNA or DENR WT did not significantly alter the number of primary neurites (two-way ANOVA F(2,51) = 2.846; p = 0.0673; n = 17–20
neurons per condition) or their branch points (two-way ANOVA F(2,51) = 1.358; p = 0.2662; n = 17–20 neurons per condition).
Graphs plot mean ± SEM. The scale bars represent (A) 200 mm and (C) 25 mm.
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expression ofDenr led to a significant reduction in dendritic spine
densities on apical and basal dendrites (Figures 4A and 4B). In
addition, we analyzed the shapes of dendritic spines and found
that perturbations to Denr did not significantly alter the ratios
of different spine types (classified as filopodia-, long-thin-,
stubby-, and mushroom-shaped) on apical and basal dendrites
(Figure S4). However, wewere interested to investigate the prop-
erties of mushroom-shaped spines, known to represent mature
synaptic contacts between neurons. We found that knockdown
of endogenous Denr led to a significant increase in the diameter
of mushroom-shaped spines on the apical as well as basal den-
drites of cortical neurons, with DENR overexpression leading to
a significant effect on spine head diameter on apical dendrites
(Figures 4C and 4D). These results demonstrate thatDenr pertur-
bations impair the dendritic arborization, dendritic spine density,
and spine morphology of cortical projection neurons.
Substitution Mutations to DENR Impair Its Neuronal
Differentiation Functions
DENR was originally characterized as a growth-related protein
(Mazan-Mamczarz and Gartenhaus, 2007; Reinert et al., 2006),
comprising a SWIB/MDM2 domain predicted to mediate chro-
matin remodeling and transcriptional activation, as well as an6 Cell Reports 15, 1–15, June 7, 2016eIF1-like/SUI1 domain known to be important for recognition
of the initiation codon and enabling efficient mRNA translation
(Kasperaitis et al., 1995; Reinert et al., 2006). We performed
amino acid sequence alignment and observed that the C37Y
substitution mutation lay within the N-terminal SWIB/MDM2
domain, which is highly conserved from Drosophila to humans,
whereas the P121L substitution mutation is located adjacent to
its C-terminal eIF1/SUI1 domain and does not show evolutionary
conservation with Drosophila Denr (Figure S5A). In order to un-
derstand the potential impact of substitution mutations C37Y
andP121L onDENR,we first performed co-immunoprecipitation
studies using HEK293T cells transiently transfected with expres-
sion constructs encoding FLAG-tagged DENR C37Y and DENR
P121L to find that both variants interact with MCTS1 (Figure 5A).
In biological repeats of this assay, we observed that the binding
capacity of myc-MCTS1 for DENR C37Y and P121L was not
significantly different to DENR WT (assessed as the intensity of
immunoprecipitated myc-MCTS1 signal relative to input myc-
MCTS1 signal; see Figure S5B). However, we also observed a
consistent reduction in myc-MCTS1 immunoblotting signal in
co-transfection assays with myc-MCTS1 and FLAG-DENR
C37Y (see Figure S5C), suggesting in this context that the pres-
ence of DENR C37Y could influence myc-MCTS1 expression
and, thus, lead to DENR-MCTS1 dysfunction.
Figure 4. The Effects of DENR Perturbations on the Dendritic Spine Properties of Cortical Projection Neurons
(A) Image reconstruction of confocal microscopy analyses to study dendritic spines from apical and basal dendrites of GFP-labeled neurons (see Experimental
Procedures).
(B) Treatment with Denr shRNA or forced expression of DENR WT led to a significant decrease in the density of dendritic spines along apical dendrites (control
8.417 ± 0.4771;Denr shRNA 6.350 ± 0.3839; DENRWT 6.768 ± 0.3091; one-way ANOVA F(2,44) = 7.598; p = 0.0015; n = 15–17; Bonferroni multiple comparisons
**p < 0.01) as well as basal dendrites (control 9.122 ± 0.3651; Denr shRNA 6.476 ± 0.3171; DENR WT 7.938 ± 0.3751; one-way ANOVA F(2,52) = 13.82;
p < 0.0001; Bonferroni multiple comparisons *p < 0.05; ***p < 0.005).
(C) Apical dendrite mushroom spine morphology. Treatment with Denr shRNA significantly increased the volume of mushroom-shaped spines compared to
control (control 0.3070 ± 0.0089; Denr shRNA 0.3488 ± 0.01627; one-way ANOVA F(2,565) = 2.856; p = 0.0584; Bonferroni multiple comparisons *p < 0.05),
whereas treatment with Denr shRNA and DENR WT significantly altered spine diameter (control 0.5082 ± 0.007397; Denr shRNA 0.5451 ± 0.01111; DENR WT
0.5655 ± 0.01259; one-way ANOVA F(2,565) = 9.076; p = 0.0001; Bonferroni multiple comparisons **p < 0.05; ***p < 0.005).
(D) Basal dendrite mushroom spine morphology. Whereas treatment conditions did not significantly affect the volume of mushroom-shaped spine heads on
apical (two-way ANOVA F(2,565) = 2.856; p = 0.0584) and basal (two-way ANOVA F(2,468) = 1.209; p = 0.2994) dendrites, treatment withDenr shRNA significantly
altered the spine diameter of apical dendrites (control 0.5066 ± 0.008637; Denr shRNA 0.5389 ± 0.01056; one-way ANOVA F(2,468) = 3.144; p = 0.0440;
Bonferroni multiple comparisons *p < 0.05).
Graphs plot mean ± SEM. The scale bars represent (A) 20 mm and (A insets) 5 mm.
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using two cell-based reporter assays. It was recently reported
that one important function for DENR is to regulate mRNA
translation during Drosophila development through a mecha-
nism involving translation re-initiation after a stuORF sequence
(Schleich et al., 2014). We evaluated the capacity of DENR and
its substitution variants to reconstitute stuORF-dependent lucif-
erase reporter activity (Schleich et al., 2014) in Drosophila S2
cells where endogenous Denr had been knocked down (Schleich
et al., 2014). As shown in Figure 5B, whereas knockdown of
Drosophila denr using two different siRNA reagents (ds DENRand dsDENR short) led to a reduction in stuORF reporter activity,
this reduction could be partially but significantly rescued by hu-
man DENR WT and P121L, but not by C37Y (Figures 5B and 5F;
(4,10) = 88, p < 0.0001 with dsDENR dsRNAs; F(4,10) = 117,
p < 0.0001 with short dsDENR dsRNAs; two-way ANOVA with
post hoc multiple comparisons testing). In a parallel experiment,
we evaluated the potential for DENR and its substitution variants
to augment reporter activity under the control of a heterologous
human stuORF reporter in HeLa cells. Rescue experiments
were performed with expression constructs that were refractory
to siRNA-mediated silencing (see Experimental Procedures).Cell Reports 15, 1–15, June 7, 2016 7
Figure 5. Characterization of DENR and Its Substitution Variants
(A) Representative images of co-immunoprecipitation experiments performed in triplicate with lysates of transiently transfected HEK293T cells demonstrate that
FLAG-DENR(WT), FLAG-DENR(C37Y), and FLAG-DENR(P121L) immunoprecipitate MYC-MCTS1 in vitro.
(B)DrosophilaS2cells, treatedwithdsRNAs to knockdownendogenousDENR,were transfectedwith astuORF-containingRenilla luciferase reporter andacontrol,
normalization firefly luciferase reporter, to assay translation downstream of uORFs, together with constructs expressing wild-type or mutant versions of human
DENR. In this assay, treatment with human DENR(WT) or DENR(P121L) significantly enhances reporter activity, whereas treatment with DENR(C37Y) does not.
(C) DENR and its substitution variants stimulate luciferase reporter activity under the control of a heterologous human stuORF. HeLa cells were treated with non-
targeting control siRNA or DENR siRNAs and then re-constituted with constructs expressing DENR(WT), DENR(C37Y), or DENR(P121L) harboring silent mu-
tations, which render them refractory to siRNA-mediated silencing (see Experimental Procedures). Cells were also transfected with an stuORF containing Renilla
luciferase reporter and a normalization control firefly reporter to assay translation downstream of stuORFs. DENR(C37Y) is impaired in its ability to stimulate
reporter expression, whereas the capacity for DENR(P121L) to stimulate reporter activity is variable, as judged in biological replicates (Figure S5D).
(D and E) An in vivo assay to study the capacity for disease-associated DENR variants to restore the defective migration of E14.5-born, GFP-labeled cells treated
withDenr shRNA and analyzed within the E17.5 cortex. Whereas co-delivery of DENRWT promoted the migration of GFP-labeled,Denr shRNA-treated cells into
the CP compared to Denr shRNA (Denr shRNA 0.287 ± 0.039; Denr shRNA + DENR WT 0.435 ± 0.036; one-way ANOVA F(6,45) = 4.805; p = 0.0007; Bonferroni
multiple comparison *p < 0.05; n = 3–6) co-treatment with DENRC37Y or with DENR P121L did not augment the defective migration ofDenr shRNA-treated cells.
Graphs plot mean ± SEM. The scale bar (D) represents 50 mm.
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variant was unable to restore reporter activity resulting from
siRNA-mediated DENR knockdown, whereas both WT and
P121L augmented stuORF-mediated reporter activity in this
assay (Figure 5C). In biological replicates of this experiment,
our results demonstrated that the capacity for P121L to augment
luciferase expression under the human stuORF reporter in HeLa
cells was variable (Figure S5D), and this variability in reporter
activation may be a pathological feature of the P121L substitu-
tion variant.
We investigated the possibility that substitution mutations to
DENR might disrupt its neuronal functions during cerebral
cortical development. We first characterized both FLAG-tagged
DENR C37Y and DENR P121L protein expression in E14.5-born
CP neurons within the E17.5 cortex by electroporation and
observed that their cellular localization is similar to FLAG-
DENR (WT; Figure S5E). Next, we electroporated Denr shRNA-
treated E14.5 cortical cells together with DENR WT, DENR
C37Y, and DENR P121L to study the positioning of E14.5-
born, GFP-labeled cells within the cortex harvested 3 days later
(at E17.5). Our results show that, whereas themigration defect of
Denr shRNA-treated cells can be corrected with co-delivery of
DENR, co-delivery of DENRC37Y or DENR P121L variants failed
to correct their defective migration (Figures 5D and 5E). Thus, we
find that C37Y and P121L substitution mutations impair the
radial migration functions for DENR in vivo.
Given that both substitution variants of DENR interact with its
in vivo binding partner MCTS1 and thus are predicted to function
in a dominant fashion, we studied the effects of their forced
expression on the long-term positioning of cortical neurons. In
contrast to the lack of an effect of DENR WT overexpression
on long-term positioning (Figure S3A), we found that forced
expression of DENR C37Y or DENR P121L resulted in the defec-
tive long-term positioning of E14.5-born cortical neurons within
the P17 cortex, observed as a significant decrease in the propor-
tion of GFP-labeled neurons in layers II–IV, and a concomitant in-
crease in the proportion of GFP+ cells residing in layer V (Figures
6A and 6B). The migration profile of neurons overexpressing
DENR C37Y and DENR P121L are different to DENRWT overex-
pression, given that DENRWT overexpression has no significant
effect (Figures S6A and S6B, respectively). Given our MRI
studies of the patient harboring a DENR P121L substitution mu-
tation that revealed features consistent with neuronal migration
disorder, including nodular heterotopia (Table S1), we looked
for evidence of such a phenotype in our in vivo experiments.
We detected the presence of heterotopic clusters of GFP-
labeled cells lying adjacent to the ependymal zone in four out
of ten (40%) of brains electroporated with DENRP121L, whereas
heterotopic clusters of cells were only detected in two out of ten
brains electroporated with DENR C37Y (Figures S6C and S6D).
This is in contrast to control as well as Denr shRNA-treated
brains in which heterotopia was detected in only one out of ten
(10%) brains. Interestingly, forced expression of human DENR
in the presence of endogenous mouse Denr also led to an in-
crease in heterotopia formation (four out of ten brains [40%]).
Immunostaining revealed that clusters of GFP-labeled cells
comprised CUX1+ neurons as well as CUX1 cells, thereby sug-
gesting that a subset of these cells was correctly specified asupper layer II–IV neurons, but failed to reach their appropriate
laminar position. Therefore, our results indicate that, like WT hu-
man DENR, forced expression of DENR C37Y and DENR P121L
impairs the long-term positioning of cortical neurons and in-
duces the formation of cortical heterotopia, albeit with different
potencies.
We investigated the consequences of forced expression of
DENR C37Y or DENR P121L on the dendritic arborization and
dendritic spine features of P17 cerebral cortical neurons. Our
Sholl analyses revealed that forced expression of DENR C37Y
or DENR P121L led to an increase in the dendritic complexity
of neurons at specific, proximal locations (C37Y: 40–65 mm;
P121L: 30–50 mm) relative to the cell soma (Figures 6C, 6D,
and S6E–S6G), with no significant changes to the numbers of pri-
mary neurites or their branch points (Figures 6E and 6F). Howev-
er, we found that forced expression of DENR C37Y or DENR
P121L did not enhance dendritic complexity to the extent that
was observed with forced expression of native DENR (Figures
S6E, S6H, and S6I), suggesting that both substitution variants
of DENR were disrupted in their capacity to augment dendritic
arborization. This finding is consistent with our findings that
forced expression of DENR WT, DENR C37Y, and DENR
P121L leads to distinct effects on the long-term positioning
and the frequency of heterotopia formation.
In addition to changes in dendritic branching, we observed
that treatment with DENR C37Y or DENR P121L led to a reduc-
tion in dendritic spine densities on apical and basal dendrites
(Figures 6G and 6H). However, whereas the presence of DENR
C37Y or DENR P121L did not significantly affect the morphology
of dendritic spines (Figures S6J and S6K), we found that pres-
ence of the P121L variant led to a significant decrease in the vol-
ume of mushroom spine heads on apical and basal dendrites
(Figures S6L and S6M; summarized in Table S2). Thus, the pres-
ence of missense variants of DENR impairs the positioning,
terminal arborization, and dendritic spine densities of cerebral
cortical neurons.
DISCUSSION
We have identified important functions for DENR during neuro-
development. We find that DENR is critical for radial migration
within the embryonic cerebral cortex, and this role requires its
binding partner MCTS1. In addition, perturbations toDenr impair
the long-term positioning and terminal differentiation of cortical
projection neurons. Furthermore, we have characterized substi-
tution variants of DENR detected in human subjects with neuro-
logical disorders and found that the presence of mutated DENR
disrupts its functions in mRNA translation in vitro and is detri-
mental to the development of cerebral cortical neurons in vivo.
In the course of cerebral cortex development, newborn
cortical projection neurons undergo a well-documented process
of cell migration as they find their appropriate positions within
this nascent organ (Kriegstein and Noctor, 2004; Nadarajah
et al., 2002, 2003; Noctor et al., 2004). In particular, these neu-
rons undergo a multipolar mode of migration as they transit
from the IZ to the cortical plate before completing their migration
via radial-glial-guided locomotion as bipolar-shaped neurons
(Heng et al., 2010; Noctor et al., 2004). Our studies linkCell Reports 15, 1–15, June 7, 2016 9
(legend on next page)
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cortical neuron development. Notably, it is recognized that radial
migration during cerebral cortex development is sensitive to ge-
netic disruptions that alter the expression levels of critical migra-
tion-related factors (Causeret et al., 2009; Heng et al., 2010;
LoTurco and Bai, 2006). Hence, our study identifies DENR as a
player in this process that acts in a concentration-sensitive
manner. Given our finding that DENR is distributed throughout
the cell, including in the leading process of CP neurons within
the embryonic cortex, we predict that DENR could be important
for coordinating the morphology of migrating cells, the orienta-
tion of their leading processes for their directional migration, or
both. As neurons complete their migration over the course of
postnatal neurodevelopment, we find that disruptions to Denr
impair the long-term positioning of cortical projection neurons.
It is noteworthy that forced expression of DENR and its substitu-
tion variants disrupted the long-term positioning of cortical pro-
jection neurons and induced heterotopia formation in different
ways. We conclude that the presence of DENR and its substitu-
tion variants leads to distinct consequences for neuronal
positioning and suggests that heterotopia formation may be a
pathological feature in DENR diseased states.
Within the postnatal cerebral cortex, neurons that have
completed their migration undergo terminal dendritic branching
and form appropriate connections with projection neurons as
well as interneurons in a highly organized manner (Harris and
Mrsic-Flogel, 2013; Markram et al., 2004). This includes parval-
bumin-expressing basket cells targeting the soma and proximal
dendrites of cortical neurons to stabilize the activity of local
excitatory networks (Harris and Mrsic-Flogel, 2013). We find
that knockdown of endogenous Denr or overexpression of
DENR disrupted the dendritic branching of cortical projection
neurons proximal (30–50 mm) to their soma and led to a reduction
in dendritic spine densities. Thus, our results indicate that pertur-
bations to DENR expression levels could lead to imbalances in
excitatory and inhibitory tone, which, in turn, may trigger epilep-
tiform activity, such as was detected in our patient harboring a
p.P121L missense mutation. Furthermore, Denr gene disrup-Figure 6. The Presence of DENR C37Y and DENR P121L Disrupts the
Properties of Cortical Projection Neurons
(A) In utero electroporation to study the effects of forced expression of DENR C3
cells within the P17 postnatal cortex, illustrated as representative coronal sectio
(B) There is a significant interaction between treatment groups and the positioning
control, there is a significant reduction in the proportion of GFP+ cells in layers I
0.947 ± 0.0103; Dunnett’s multiple comparisons ***p < 0.005) as well as P121
comparisons **p < 0.01), along with a concomitant increase in the proportion of G
0.010 ± 0.005; DENR C37Y 0.033 ± 0.0077; DENR P121L 0.0348 ± 0.0110; Dunn
(C) Representative images of GFP-labeled, layer II/III cortical projection neurons
(D) Sholl analysis of dendritic branching complexity reveals alterations to region
neurons (C37Y: 40–65 mm; P121L: 30–50 mm; as well as Figures S6F and S6G).
(E and F) Forced expression of DENR C37Y and DENR P121L did not significan
p = 0.3602; n = 17–20 neurons per condition) or their branch points (two-way
compared with control (GFP-only treatment).
(G) Confocal microscopy and image reconstruction of dendritic spines from apic
(H) Following treatment with DENR C37Y or DENR P121L, there is a significant de
0.4771; DENR C37Y 6.844 ± 0.2217; DENR P121L 6.295 ± 0.2217; one-way ANOV
***p < 0.005) as well as basal dendrites (control 9.122 ± 0.3651; DENR C37Y 7.6
p = 0.0126; Bonferroni multiple comparisons test *p < 0.05).
Graphs plot mean ± SEM. The scale bars represent (A) 200 mm, (C) 25 mm, (G) 2tions significantly altered the shape and volume of mushroom-
shaped spine heads (summarized in Table S2). Typically, large
spines have proportionally larger synapses and contain a greater
diversity of synaptic proteins and organelles, such as smooth
endoplasmic reticulum for local synthesis of synaptic proteins
(Hering and Sheng, 2001). As it is also known that the size of
the spine head is proportional to the area of the post-synaptic
density, we predict that DENR is important for the strengthening
of synaptic transmission between neurons, with implications for
its functions in human brain development and autism spectrum
disorder.
In eukaryotes, canonical mRNA translation is carried out on
mature cellular mRNAs that bear a 50 cap structure (m7G) and
a 30poly(A) tail (Hinnebusch and Lorsch, 2012). These capped
mRNAs are recognized by eIF4F, which functions to recruit the
ribosomal 43S complex containing eIF2a to facilitate translation.
However, the ribosomal 43S complex can also bind uncapped
mRNAs and internal ribosomal entry sites (IRES) of viral tran-
scripts in conjunction with DENR (Skabkin et al., 2010, 2013;
Zinoviev et al., 2015). DENR facilitates the efficient translation
re-initiation of transcripts bearing an stuORF either by release
of deacylated tRNA or recruitment of aminoacylated tRNA
(Schleich et al., 2014; Skabkin et al., 2010, 2013). Another trans-
lation factor, ligatin/eIF2D, contains a SWIB/MDM2 domain
homologous to DENR in its N-terminal half, as well as an eIF1-
like/SUI domain homologous to MCTS1 in its C-terminal half,
and has functions in translation that overlap with those of
DENR and MCTS1 (Dmitriev et al., 2010; Skabkin et al., 2010,
2013; Zinoviev et al., 2015). Whereas it has recently been
demonstrated that loss of DENR during Drosophila embryo
development leads to impaired tissue growth and larval forma-
tion (Schleich et al., 2014), reductions in ligatin gene dosage
were found to exacerbate the defective development of DENR-
knockout flies (Schleich et al., 2014), suggesting overlapping
functions for DENR and LIGATIN in embryo development. We
found that knockdown of Denr andMcts1, or both, in the neural
cell line Neuro2a did not significantly alter steady-state levels of
ligatin (data not shown). Also, LIGATIN expression is very weaklyLong-Term Positioning, Dendritic Branching, and Dendritic Spine
7Y and DENR P121L on the long-term positioning of E14.5-born, GFP-labeled
ns from each.
of GFP+ cells within the P17 cortex (F(8,75) = 3.93; p = 0.0006). Compared to
I–IV following treatment with DENR C37Y (control 0.984 ± 0.008; DENR C37Y
L (control 0.984 ± 0.008; DENR P121L 0.9532 ± 0.0148; Dunnett’s multiple
FP+ cells in layer V in both DENR C37Y- and DENR P121L-treated cells (control
ett’s multiple comparisons *p < 0.05).
from each condition.
al dendritic branching complexity in DENR C37Y- and DENR P121L-treated
tly affect the numbers of primary neurites (two-way ANOVA F(2,52) = 1.041;
ANOVA F(2,52) = 1.022; p = 0.3668; n = 17–20 neurons per condition) when
al and basal dendrites of GFP-labeled neurons.
crease in the density of dendritic spines along apical dendrites (control 8.417 ±
A F(2,49) = 11.62; p < 0.0001; Bonferroni multiple comparisons test **p < 0.01;
64 ± 0.3635; DENR P121L 7.664 ± 0.3635; one-way ANOVA F(2,52) = 4.759;
0 mm, and (G insets) 5 mm.
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and MCTS1 (Figures S1C–S1E), which seems inconsistent with
completely redundant roles for DENR/MCTS1 and LIGATIN
in the nervous system. Future work will clarify the relative
importance for overlapping functions between DENR/MCTS1
and LIGATIN in mammalian neuronal development.
Our study provides evidence for an evolutionary conservation
of human DENR function on a Drosophila stuORF, and we find
that C37Y and P121L substitution mutations disrupt the ability
for DENR to facilitate mRNA translation re-initiation through a
Drosophila stuORF as well as a heterologous human stuORF re-
porter in different ways. Whereas it will be informative to deter-
mine whether both substitutions could disrupt the role for
DENR in other aspects of mRNA translation, including ribosome
recycling and termination-dependent and -independent re-initia-
tion of viral mRNAs (Skabkin et al., 2010; Zinoviev et al., 2015),
our current findings nonetheless provide critical mechanistic
insight into the pathological consequences of DENR substitution
mutations in mRNA translation and link its altered molecular
functions to human neurological disease. As such, our studies
provide an important context for DENR-MCTS1 functions within
the mammalian nervous system and suggest that neural cells
require activity of DENR-MCTS1 for regulating mRNA translation
so as to coordinate cell migration and terminal neurodifferentia-
tion during cerebral cortex development.
It is noteworthy that a C37Y substitution variant was detected
in a patient diagnosed with autism, whereas a P121L mutation
was detected in a patient diagnosed with epilepsy as well as
Asperger syndrome, an autism spectrum disorder. Given the
compelling documentary evidence for abnormal cortical organi-
zation (Stoner et al., 2014) and defective neuronal positioning
(Wegiel et al., 2010) in children diagnosed with autism, our find-
ings are consistent with the notion that certain clinical presenta-
tions of autism spectrum disorder could be delineated on the
basis of candidate gene mutations, including to DENR, which
disrupt core signaling pathways for neural circuit organization
and synaptic function (Liu et al., 2014; Neale et al., 2012). Our
future investigations will clarify the nature of DENR missense
substitutions in human neuronal development and define their




The collection and sequencing of DNA from the index patient with structural
brain abnormalities is authorized under two separate ethical frameworks
administered by the Wales Research Ethics Committee (08/MRE09/55 and
12/WA/0001) of the UK. Whole-exome sequencing was performed on DNAs
extracted from patient and parental blood samples. Libraries were prepared
using standard procedures, captured using the SureSelect Human all exon
kit (Agilent Technologies), and then sequenced using Illumina technology.
The 51-bp paired-end reads were mapped using Stampy (Lunter and
Goodson, 2011), and duplicate PCR reads were removed using Picard
(http://picard.sourceforge.net/). Single-nucleotide variants were called using
Platypus (Rimmer et al., 2014).
Animals
C57BL/6J wild-type mice were bred, housed, and time mated according to
standard operating procedures approved by the Animal Ethics Committee at12 Cell Reports 15, 1–15, June 7, 2016Monash University (MARP/2012/069) and UWA (AE201) and compliant with
guidelines stipulated by the National Health and Medical Research Council
of Australia.
Expression Constructs
Expression constructs were prepared according to standard molecular
cloning procedures. N-terminal MYC-tagged MCTS1 cDNA was cloned into
pCIG2; human DENR and DENR substitution mutations c.G110A and
c.C362T were cloned into pCIG-Flag expression vector, as well as with a
pCIG-Flag vector in which the GFP cassette was excised by restriction diges-
tion and subsequent cloning. Denr oligonucleotides with appropriate hairpin
sequences targeting mouse Denr (1: 50-CCAAGTTAGATGCGGATTA; 2:
50-CCACAGAAGGTCACGATAG) were cloned into the pSilencer-EGFP
expression vector, and a non-targeting scrambled control pSilencer-EGFP
(Bron et al., 2007) was used as the control in all RNAi experiments. All expres-
sion constructs used in vivo were prepared using QIAGEN DNA purification
products with endofree reagents, according to manufacturers’ instructions,
and eluted in water. All products were sequence verified. ON-TARGET plus
SMARTpool siRNAs targeting mouse Denr and Mcts1 were purchased from
Dharmacon and reconstituted in water for use at 5 mM. The efficacy of knock-
down by siRNAs and shRNAs were confirmed by Lipofectamine transfection
with the neuroblastoma Neuro-2A cell line, lysates of which were harvested
for western blotting or qRT-PCR 48 hr later.
Luciferase reporter constructs for testing in Drosophila S2 cells were as fol-
lows: a Firefly reporter pGL3:hsp70>>firefly luciferase, containing the 50 UTR
of Drosophila gene CG4637 (cloned via PstI/NcoI), served as a normalization
control. pGL3:hsp70>>Renilla luciferase containing the same 50 UTR, with or
without a synthetic stuORF, served as the experimental readout. Luciferase re-
porter constructs for testing in HeLa cells were constructed via a multistep
cloning procedure, resulting in two plasmids, each bearing both a Renilla lucif-
erase gene as well as a normalization control firefly luciferase gene, with the
difference that one of the two plasmids contains a stuORF upstreamof the
Renilla luciferase (the ‘‘stuORF reporter’’) whereas the control reporter plasmid
does not. The plasmids have the following features in sequential order:
pGL3Promotor (Promega) backbone; a cytomegalovirus (CMV) promotor; 50
UTR ofDrosophila gene CG43674; Firefly luciferase reporter ORF; SV40 polyA;
CMV promotor; 50 UTR of CG43674 (without stuORF in the control reporter or
bearing a synthetic stuORF in the stuORF reporter); Renilla luciferase reporter
ORF; and SV40 polyA. Human DENR ORF was amplified by PCR from HeLa
cDNA with EcoRI and NotI overhangs. The PCR product was cloned into
the TOPO TA vector (Invitrogen), fully sequenced, and subsequently subcl-
oned into the EcoRI-NotI sites of pCDNA3. To render the hDENR ORF insen-
sitive to knockdown with hDENR siRNA (Dharmacon siGENOME siRNAi
D-012614-02), the siRNA target site was mutated by point mutagenesis to
introduce silent mutations using oligos OSS388 and OSS389, yielding the
‘‘wild-type’’ rescue construct. The C37Y or P212L mutations were then intro-
duced by site-directed mutagenesis. For expressing in Drosophila S2 cells,
wild-type and C37Y or P212L mutant hDENR ORFs were cloned into pMT
via EcoRI and NotI sites. For all constructs utilized in this study, full sequences
are available upon request.
Cell Culture, Western Blotting, and Co-immunoprecipitation
Cell culture for immunoprecipitation assays and western blotting was per-
formed as previously described (Breuss et al., 2012; Gladwyn-Ng et al.,
2015). Antibodies used in this study (listed by species) include mouse anti-
immunoglobulin G (IgG) (Millipore) anti-b-actin (A5441; Sigma-Aldrich), anti-
FLAG (F1804; Sigma-Aldrich), anti-MYC (Sigma-Aldrich), anti-Tuj1 (MMS-
435P; Covance), anti-GFAP (Millipore), anti-DENR (Santa Cruz Biotechnology);
rabbit anti-DENR (Novus Biologicals), anti-MCTS1 (Novus), anti-FLAG (Cell
Signaling Technology), anti-CDP (sc-6327, Cux1; Santa Cruz), anti-activated
caspase-3 (R&D Systems), anti-Myc (Abcam); goat anti-MCTS1 (Santa
Cruz); and chicken anti-GFP (Ab13970; Abcam). Preimmunized goat serum
(Sigma) was used for immunoprecipitation experiments as a control. Cell
nuclei were visualized with DAPI.
For experiments with Drosophila S2 cells, double stranded RNA (dsRNA)-
targeting dDENR was added to medium at a concentration of 12 mg/ml and
incubated for 3 days. Following this, luciferase reporter constructs and hDENR
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manufacturer’s instructions. On the 4th day, medium was changed to fresh
serum-free media (SFM) containing additionally 0.175 mg/ml of copper sulfate
for induction of ‘‘rescue’’ protein expression and luciferase assays were per-
formed the following day. When conducting luciferase reporter assays with
HeLa cells, 96-well microtiter plates were seeded at 12,000 cells/well. Knock-
down was achieved with a mix of three different siRNAs from Dharmacon tar-
geting hDENR (D012614-19 and D-012614-20 targeting the 30 UTR of endog-
enous hDENR plus D-012614-02 targeting the coding sequence, which was
mutated in the rescue constructs mentioned above), or negative control siRNA
(Ambion) at a final concentration of 5 pmol/well was performed with RNAiMax
(Life Technologies) and incubated for 2 days. Following this, cells were trans-
fected with pCDNA3 rescue constructs (wild-type, C37Y, or P121L) and lucif-
erase reporter plasmids and incubated another day before the dual luciferase
assay was performed. Where relevant, signals between conditions were eval-
uated using Student’s t tests or one-way or two-way ANOVA analyses fol-
lowed by an appropriate post hoc t test corrected for multiple testing.
qRT-PCR, Western Blotting, and Immunoprecipitation
For qRT-PCR, total mRNA was extracted from mouse brain tissues at five
different time points, E11.5, E14.5, P0, P10, and young adult (P30) was used
for reverse transcription. Quantitative real-time PCR employed exon-spanning
primers, Denr (forward: 50-AAAAATTCTCGTGCGGTGCC; reverse: 50-CATC
CGCCTCTGGCCACTTT) and Mcts1 (forward: 50-CTTGCCACATCAGCAG
GTTG; reverse: 50-AGCTTAGCTCCGGGAGAAGT), withPgk1 (forward: 50-AAA
CTCAGCCATGTGAGCACT; reverse: 50-ACTTAGGAGCACAGGAACCAAA) as
an internal control gene. Each qPCR reaction consisted of 10 ng/ml template
cDNA, 5 mM target gene primers, or 10 mM housekeeping gene primers. The
levels ofDenr andMcts1were expressed relative toPgk1, and signals between
conditions were evaluated using Student’s t tests.
Immunoprecipitation and western blotting were carried out as follows.
Briefly, cultured cells and brain tissue were lysed using lysis buffer (20 mM
Tris [pH 7.5], 150 mMNaCl, 1% IGEL-PAL, 0.1% SDS, and protease inhibitor),
whereas brain tissue for immunoprecipitation experiments was lysed using
Promega Cell Culture Lysis 53 Reagent (cat. no. E153). Brains were homoge-
nized and protein concentration measured using Bradford reagent (Bio-Rad).
For immunoprecipitation, 1mg protein was incubatedwith 1.0–1.5 mg antibody
overnight at 4Cwith rotation, followed by incubation with protein A Sepharose
beads for 2 hr at 4C. Immunoprecipitated proteins were eluted with 50 mM
glycine. Protein samples were analyzed on a 10% SDS gel, transferred to
nitrocellulose membrane, and incubated overnight with primary antibodies.
Membranes were incubated with anti-rabbit LI-COR Biosciences IRDye 680
LT or anti-mouse LI-COR Biosciences IRDye 800 secondary antibodies for
1 hr before analysis using the Odyssey imaging system (LI-COR Biosciences;
9201-02).
In Utero Electroporation
In utero electroporation was performed according to the methodology devel-
oped by Tabata and Nakajima (2003), with modifications we have described
previously (Haas et al., 2013; Ngo et al., 2014). Briefly, time-mated pregnant
(E14.5) C57BL/6J female mice were anesthetized with sodium pentobarbitone
and incisions made in the skin and peritoneum. The uterus was exposed from
the abdomen, and the lateral ventricle of embryos was injected with a solution
containing 1 mg/ml of each species of DNA expression plasmid, 5 mM siRNA
(when indicated), and Fast Green tracer dye. The quantities of expression
plasmid (1 mg/ml), shRNA vector (1 mg/ml), and siRNAs (5 mMsiRNA) for injection
were balanced for all electroporation experiments to enable comparisons
between conditions in our data. Following electroporation with a square-pulse
generator, the uterine horns were returned to the abdominal cavity and the
peritoneal and skin incisions sutured. Electroporated brains were harvested
after 3 days (E17.5) or at P17. Where relevant, migration profiles between
conditions were evaluated through two-way ANOVA analyses followed by an
appropriate post hoc t test corrected for multiple testing.
Tissue Collection, Fixation, and Immunohistochemistry
At E17.5, brains were dissected and fixed overnight in 4% paraformaldehyde
(PFA), whereas P17 mice were anesthetized with sodium pentobarbitone andtranscardially perfused with PBS followed by 4% PFA and then post-fixed
overnight in 4% PFA. Brains were cryoprotected in 20% sucrose and then
cryostat sectioned at 16 mm (E17.5) or 40 mm (P17) thickness. P17 sections un-
derwent free-floating immunohistochemistry, whereas E17.5 immunohisto-
chemistry was performed on slides, using standard protocols (Heng et al.,
2008; Ngo et al., 2014). Sodium citrate (0.01 M) antigen retrieval was used in
some cases to enhance immunolabeling. Species-appropriate Alexa Fluor
(Molecular Probes) secondary antibodies were used for immunofluorescence
detection. For E17.5 experiments, images were captured using an Olympus
microscope equipped with a charge-coupled device (CCD) camera (SPOT).
Subdivisions of the embryonic cortex (VZ, IZ, and CP) were identified based
on cell density visualized by DAPI staining. Cell counting was performed blind
to the condition on representative fields of sections of electroporated brains
using ImageJ (1.47 m) software.
For in utero studies that focus on GFP-labeled neurons within the P17
cortex, electroporations were performed with injection mix, which comprised
equal quantities of expression vector and shRNA vector to enable compari-
sons between conditions. That is, 1 mg/ml of pCIG construct was co-delivered
with 1 mg/ml of pSil-Caggs shRNA vector (control, pCIG + psil-Caggs-scr;
shRNA, pCIG + pSil-Caggs-Denr shRNA1; DENR, pCIG-F-DENR + pSil-
Caggs-scr; C37Y, pCIG-F-DENR(C37Y) + pSil-Caggs-scr; P121L, pCIG-F-
DENR(P121L) + pSil-Caggs-scr). GFP-labeled P17 neurons were captured
as 3D confocal images of 40-mm-thick mouse brain sections and digitally re-
constructed using Filament Tracer (Imaris 7.6.2; Bitplane). This analysis was
conducted on GFP-labeled cortical projection neurons residing within layers
II/III of the somatosensory cortex of successfully electroporated P17 brains.
For cell morphology analysis, neurons were captured at 403 magnification,
whereas for dendritic spine studies, neurites were imaged at 603 magnifica-
tion, with 1 mm z-stack step size. Both rendering of neuronal cell morphology
as well as the identification of dendritic spines were performed manually,
whereas the classification of spine types was automatically calculated based
on pre-defined parameters, as described recently (Ngo et al., 2014). Repre-
sentative images of projection neurons identified from each condition were
prepared with Photoshop using non-linear image manipulation. Imaris Soft-
ware reported results from statistical tests related to the analyses of neuronal
morphology and dendritic spines properties.
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Experiment 2 Experiment 3 Experiment 4 
Homo sapiens      ---MAADISESSGADCKGDPRNSAKLDADYPLRVLYCGVCSLPTEYCEYMPDVAKCRQWL 57
Mus musculus ---MATDISESSGADCKGDTKNSAKLDADYPLRVLYCGVCSLPTEYCEYMPDVAKCRQWL 57
Xenopus Laevis MASIAIENAEPVPSDCKGDLKIS-KFDGDLPLKVLYCGVCSLPTEYCEYMPDVAKCRQWL 59
Danio rerio --MATTENAESGSPENKVDRADP---DAKYPLKVLYCGVCSLPAEYCEYMPEPAKCKQWL 55
Drosophila melanogaster  --MTNEDVGTNSVADRLQLGPRE---GVTYPIQMKYCGHCTMPIEYCEYYPEYEKCKEWL 55
Caenorhabditis elegans --MSD---GETAVIQSLAPGPID---GVSYPLKMVYCGQCSMPPEYCDYSGQTDVCRAWA 52
.     :           .   *::: *** *::* ***:*  :   *: * 
Homo sapiens      EKNFPNEFAKLTVENSPKQEA----GISEGQG--------TAGEEEEKKKQKRGGRGQIK 105
Mus musculus EKNFPNEFAKLTVENSPKQET----GITEGQG--------PVGEEEEKKKQKRGGRGQIK 105
Xenopus laevis EKNFPDEFSKLTLGISPKQET----GTVEGQA--------TSGEEEEKKKQKRGGRGQIK 107
Danio rerio EKNFPDVFAKLTLGTAPKQESKGGGGGEDGGGGRGRGEAPPAGEEEEKKKQKRGGRGQIK 115
Drosophila melanogaster    ELHMPDDFERLKIEEEAAAADG---------------------TDDDKKRQKRGGKGLLR 94
Caenorhabditis elegans TQNAPELLEGLEISDEPAADG------------------------DEKKKQKRGGKGSKT 88
: *: :  * :   .                            ::**:*****:* 
Homo sapiens      ------------QKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFEIDLKEAQRFFAQKFS 153
Mus musculus ------------QKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFEIDLKEAQRFFAQKFS 153
Xenopus laevis ------------QKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFEIELKDAQRFFAQKFS 155
Danio rerio ------------QKKKTVPQKVTIAKIPRAKKKYVTRVCGLATFDIELKEAQRFFAQKFS 163
Drosophila melanogaster    -----------VKKKEDVPKRICVSRAARGKKKSVTVVTGLSTFDIDLKVAAKFFGTKFA 143
Caenorhabditis elegans GAAAAQAAASGGKKKGGGPQKVTLQREPRGKK-SVTVIKGLATFDIDLKVASKLFAQKFA 147
:**   *::: : : .*.**  ** : **:**:*:** * ::*. **:
Homo sapiens      CGASVTGEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIEDLGEVKK- 198
Mus musculus CGASVTGEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIEDLGEVKK- 198
Xenopus laevis CGASVTGEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIEDLGEVKK- 200
Danio rerio CGASVTAEDEIIIQGDFTDDIIDVIQEKWPEVDDDSIDDLGEVKK- 208
Drosophila melanogaster    CGSSVTGDDEIVIQGDVKDDLFDVIPEKWAEIDEDVIEDLGDQKRT 189
Caenorhabditis elegans CGSSVTGADEIVIQGDVKDDLLDLIPEKWKQVTDEQIDDLGDKKR- 192
**:***. ***:****..**::*:* *** :: :: *:***: *: 
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LEGENDS TO SUPPLEMENTARY FIGURES 
Figure S1 related to Figure 1. (A to B) A survey of DENR and MCTS1 expression in 
human brain tissue samples from human fetal (pink bars), newborn (light blue) and 
adult (yellow bars) using Capped Analysis of Gene Expression (CAGE) in 
FANTOM5 (Consortium et al., 2014). (C) An expression profile for the related factor 
LIGATIN is also provided. Quantitative data was normalized across libraries and 
expressed as Tags Per Million (TPM) mapped reads in a given CAGE library. Where 
multiple samples were available from a given tissue, data is plotted as an average + 
standard deviation. As a guide, expression levels at 10 TPM reflect approximately 3 
copies of a given transcript in a cell (Consortium et al., 2014). (D) The relative 
expression level of DENR across brain tissues was significantly higher than LIGATIN 
(p<0.0001, n=34 brain tissue libraries where expression data (TPM>0) was available 
for both genes). (E) The relative expression level of MCTS1 across brain tissues was 
also significantly higher than LIGATIN (p<0.0001, n=34 brain tissue libraries where 
expression data (TPM>0) was available for both genes).  
 
Figure S2 related to Figure 2. Evaluating Denr shRNA effects on cortical 
neuroprogenitors, as well as the effects of Denr shRNA and Mcts1 siRNA treatment 
on cell migration within the embryonic mouse cerebral cortex.  
(A) In utero electroporation was performed on E14.5 embryos to investigate the 
effects of Denr shRNA treatment on cortical progenitors within the E16.5 cortex. The 
proportion GFP-labelled cells undergoing cell division, indicated by co-expression of 
the M-phase mitosis marker phosphorylated histone H3 (pH3), was not significantly 
different (B). Co-labelling for the neuroprogenitor marker Pax6, as well as the basal 
progenitor marker Tbr2 in parallel experiments demonstrate that treatment with Denr 
shRNAs did not significantly affect the co-expression of these markers in labelled 
cells (C and D, respectively, n=6 control and 5 Denr shRNA-treated brains per 
condition). (E) In utero electroporation studies of an additional, Denr shRNA 2 
introduced into cells of the E14.5 embryonic cortex and analysed three days later at 
E17.5. (F) Treatment with Denr shRNA 2 leads to a significant reduction in the 
proportion of GFP+ cells within the CP (Control 0.543±0.062, shRNA 2 0.377±0.054, 
2-Way ANOVA F(4,54)=3.618, P=0.0110, with Bonferroni multiple comparisons 
*p<0.05, n=6-8 per condition). (G) Immunoblotting studies with Denr shRNA 1 and 
shRNA 2 showing knock down of FLAG-tagged mouse DENR (FLAG-muDENR) 
signal in lysates of transiently transfected Neuro2A cells. Parallel experiments show 
that both Denr shRNAs do not suppress FLAG-humanDENR (FLAG-huDENR) 
immunoblotting signal. (H to I) There is no significant difference in the proportion of 
cells which express the glial cell marker, GFAP (1-way ANOVA F(3,24)=2.7, 
P=0.0654) nor the pro-apoptotic marker, activated Caspase-3, between the conditions 
indicated (1-Way ANOVA F(3, 22)=2.7, P=0.681). (J) Evaluation of an expression 
construct comprising mouse wildtype Denr cDNA clone (designated as muDenr*) in 
pCIG-F vector which is refractory to Denr shRNA-mediated knockdown, as 
demonstrated a Western blotting assay with protein lysate from Neuro2a cells 
transiently transfected with a non-targeting shRNA (scr) or Denr shRNA 1 (sh1). In 
biological triplicate experiments, there is no significant difference in the amount of 
immunodetectable FLAG-muDenr* between shRNA treatments. (K to L) The 
defective migration of Denr shRNA-treated cells can be restored by co-delivery of 
muDenr* (denoted as “Denr WT rescue”). As shown, while Denr shRNA treatment 
leads to a significant impairment in GFP+ cells within the CP, this defect can be 
rescued by mouse Denr to levels which are not significantly different to control 
profile within the CP (Control 0.526+0.056, Denr shRNA 0.281+0.014, Denr WT 
rescue 0.494+0.035, n=4-5 brains per condition, 2-Way ANOVA F(4,30)=16, 
P<0.0001, with Bonferroni multiple comparisons). (M) The migration profile of GFP-
labelled cells treated with Denr shRNA together with DENR WT was not 
significantly different to Control whereby a GFP-only vector was co-delivered with a 
non-targeting shRNA vector (2-way ANOVA F(2,24)=0.4278, P=0.6568). (N) The 
migration profile of mouse Denr WT rescue cells and human DENR WT rescue cells 
was not significantly different (2-way ANOVA F(2,21)=0.95, P=0.4036). (O) 
Western blotting analysis with transiently transfected Neuro2a cells demonstrates that 
Mcts1 siRNAs suppress Mcts1 immunoblotted protein signal. (P and Q) Treatment 
with Mcts1 siRNAs did not significantly perturb migration (2-way ANOVA 
F(2,33)=0.07616, P=0.7930). (R and S) The defective migration of Denr shRNA-
treated cells was not exacerbated upon co-delivery of Mcts1 siRNAs (2-way ANOVA 
F(2,21)=0.1080, P=0.8982). Values represent mean + SEM. Scale bar = (A, E, K, P, 
R), 50μm; (H and I), 50μm (H and I insets) 15μm. 
 
Figure S3 related to Figure 3. The effects of Denr disruptions on the identity, 
dendritic branching and dendritic spine morphologies of P17 cortical neurons.  
(A) Forced expression of DENR WT does not significantly impair the long-term 
positioning of E14.5-born cells within the postnatal P17 cortex (2-way ANOVA 
F(4,50)=1.1, P=0.3583). (B) Treatment with Denr shRNA or forced expression of 
DENR WT, C37Y or P121L did not significantly affect the proportion of 
GFP+/CUX1+ cells in the cortex (1-way ANOVA F(4,10)=1.189, P=0.3732). (C to 
D) ANCOVA analysis of Sholl profiles to characterize potential differences in 
dendritic complexity of P17 cortical neurons. Graphs plot mean + SEM. (C and D) 
ANCOVA analysis of branching profiles between control (GFP-only; plotted with red 
triangles) treatment and Denr shRNA treatment (plotted with green circles) shows 
regional differences in dendritic branching. While there is no significant difference in 
the branching complexity of neurons between Sholl intersections analysed 5-25μm 
from the soma (P = 0.456), there is a significant difference in Sholl profiles analysed 
30-50μm from the soma (P < 0.05) which indicates that Denr shRNA-treated neurons 
are more simplified within this domain. (E) Forced expression of DENR WT also 
leads to a significant difference in the Sholl profile 30-50μm from the soma when 
compared with control-treated neurons (P < 0.05).  
 
Figure S4 related to Figure 4. Disruptions to DENR do not significantly alter the 
morphology of dendritic spines.  
Dendritic spine types along the apical and basal dendrites, classified as filopodia, long 
thin, stubby, mushroom. There was no significant interaction between Denr 
perturbations and dendritic spine morphologies on apical dendrites (2-way ANOVA 
F(6,176)=1.403, P=0.2158) as well as basal dendrites (2-way ANOVA 
F(6,196)=0.9675, P=0.4484). Graphs plot mean + SEM. 
 
Figure S5 related to Figure 5. Studies of FLAG-DENR(WT), FLAG-DENR(C37Y) 
and FLAG-DENR(P121L) protein in vitro and in vivo.  
(A) Multiple species alignments for DENR polypeptide sequences reveal that C37 is 
conserved between humans and drosophila, while P121 is not (key residues are 
identified in red text). (B) Quantification of immunoprecipitated myc-MCTS1 as 
immunoblotted signals relative to myc-MCTS1 input for biological triplicate 
experiments revealed no significant differences between DENR(WT), DENR(P121L) 
and DENR(C37Y) (1-way ANOVA F(2,6)=0.8183, P=0.485, n=3 biological 
replicates). (C) Quantification of MYC-MCTS1 protein signals relative to β-actin 
suggests a trend in which transfection of DENR(C37Y) results in a reduction MYC-
MCTS1 derived from co-transfected construct (1-way ANOVA F(2,3)=7.731, 
P=0.065, n=3 biological replicates). (D) Luciferase reporter assay using a 
heterologous human reporter. Multiple biological replicates indicate that 
hDENR(C37Y) consistently fails to rescue luciferase reporter activity (under the 
control of a heterologous human stuORF) as a result of siRNA-mediated loss of 
endogenous hDENR, whereas hDENR(P121L) gives highly variable results, 
suggesting a mild functional impairment. HeLa cells were treated with non-targeting 
control siRNA or siRNA targeting DENR, and then re-constituted with constructs 
expressing DENR(WT), DENR(C37Y) or DENR(P121L) which were refractory to 
siRNA-mediated silencing. (E) Immunostaining for FLAG-tagged DENR(WT), 
DENR(C37Y) and DENR(P121L) in E14.5-born cortical cells within the CP of E17.5 
brains. The cellular distribution of FLAG immunoreactivity was not qualitatively 
different between DENR WT and its variants. Graphs plot mean + SEM. Scale bar, 
(E) = 30μm. 
 
Figure S6 related to Figure 6. Distinct effects of DENR C37Y and DENR P121L 
overexpression on the long-term positioning of cortical neurons, as well as their 
dendritic complexity. 
(A) The migration profile of DENR C37Y overexpressing cells is different to DENR 
WT (2-way ANOVA F(8,80)=3.1, P=0.0042), since the migration profile of DENR 
C37Y treated cells is significantly different to Control, while DENR WT treated cells 
are not. (B) The migration profile of DENR P121L overexpressing cells is also 
significantly different, albeit to a lesser degree. (C and D) Detection of heterotopic 
clusters of GFP-labelled cells within the electroporated brains of postnatal P17 
animals following Denr disruption. The incidence of heterotopic clusters of GFP-
labelled cells within each mouse brain was variable between treatment, and we found 
clusters either comprising GFP+/CUX1- cells, or a mixture of GFP+/CUX1- cells 
together with GFP+/CUX1+ cells (C). Representative images of heterotopic clusters of 
cells identified in two independent brain samples electroporated with DENR P121L 
(D). In one brain, a cluster of cells with a mixture of CUX1+ and CUX1- cells was 
evident, while another brain sample comprised a cluster of GFP+ cells which did not 
co-label with CUX1. (E) Sholl analysis demonstrates that while forced expression of 
DENR WT enhanced the dendritic complexity of layer II/III neurons within the P17 
cortex compared to control (GFP only), DENR C37Y and DENR P121L were 
impaired in their capacity to promote dendritic complexity since their Sholl profiles 
lie under the profile plot for DENR WT. (F to G) Differences in the local dendritic 
complexity of DENR C37Y and DENR P121L treated neurons compared to control 
(GFP only) neurons. The dendritic complexity of DENR C37Y-treated neurons is 
significantly different within Sholl intersections 40-65μm from the soma, while the 
dendritic complexity of DENR P121L-treated neurons is significantly different within 
Sholl intersections 30-50μm from the soma. (H to I) Differences in the local dendritic 
complexity of DENR C37Y but not DENR P121L treated neurons when compared to 
DENR WT neurons. The dendritic complexity of DENR C37Y-treated neurons is 
significantly different within Sholl intersections 25-45μm from the soma (P < 0.05), 
while the complexity of DENR P121L-treated neurons is not significantly different to 
DENR WT neurons at this location (P = 0.153). (J and K) Analysis of dendritic spine 
shapes (filopodia, long thin, stubby, mushroom) between control, DENR C37Y and 
DENR P121L reveals no significant interaction between treatment for spine shapes on 
apical (2-Way ANOVA F(6,192=1.760, P=0.1092) and basal (2-Way ANOVA 
F(6,196=1.260, P=0.2775) dendrites. (L and M) The effects of mushroom-head spine 
volume and diameter following treatment with DENR C37Y or DENR P121L. 
Treatment with DENR P121L results in a significant decrease in the spine volume 
along apical dendrites (Control 0.3070±0.008899, DENR P121L 0.2565±0.01489, 1-
way ANOVA F(2,514)=3.993, P=0.0190, Bonferroni multiple comparison *p<0.05) 
as well as along basal dendrites (Control 0.3185±0.01339, DENR P121L 
0.2675±0.01138, 1-way ANOVA F(2, 451)=5.980, P=0.0027, Bonferroni multiple 
comparison *p<0.05). There was no significant effect of DENR C37Y or DENR 
P121L on the diameters of mushroom-shaped dendritic spines from apical (2-Way 
ANOVA F(2,514)=0.6026, P=5.478) and basal (2-Way ANOVA F(2,451)=3.062, 
P=0.0478) dendrites. Graphs plot mean + SEM. Scale bar = (D), 200μm; boxed area, 
44 μm. 





AAA  ATT  CTC  AGA Translation 
Patient (Case 2) Lys    Ile    Leu   Arg   
AAA  ATT  CCC  AGA  Translation 
Parents Lys    Ile    Pro   Arg   
Supplemental Table S1 
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LEGENDS TO SUPPLEMENTARY TABLES 
Supplemental Table S1. Summary of clinical and gene sequencing data in human 
cases of neurological disorders associated with mutations to DENR. Structural MRI 
imaging reveals paraventricular nodal heterotopia, a neuronal migration disorder. 
Sequence traces for a patient and their parents demonstrating a de novo heterozygous 
c.362C>T mutation resulting in a p.P121L substitution. See Experimental Procedures 
for further details related to data collection.  
 
Supplemental Table S2. Summary of changes detected in mushroom-shaped 
dendritic spines of layer II/III projection neurons within the P17 mouse cortex 
reported in this study (related to Figure 4 and Figure 6, as well as Supplemental 
Figures S4 and S6). Treatment with Denr shRNA or overexpression of DENR WT led 
to a significant increase in the diameter (denoted “d”) of spines, while overexpression 
of DENR P121L led to a significant increase in the volume (denoted “V”) of spine 
heads. In basal dendrites, treatment with Denr shRNA similarly led to a significant 
increase in spine diameter, while overexpression of DENR P121L led to a reduction 
in the volume of spine heads. 
 
SUPPLEMENTAL PROCEDURES 
Additional cloning of a mouse cDNA expression construct (muDenr*) refractory to 
shRNA-mediated silencing 
A mouse Denr cDNA flanked by MfeI restriction sites and comprising silent 
mutations within the targeting sequence recognized by Denr shRNA1 was 
synthesized by a commercial provider (IDT Technologies, USA) such that the 
original target sequence 5’- CCAAGTTAGATGCGGATTA-3’ was mutated to 5’- 
CAAAGTTGGACGCCGATTA 3’ (underlined text represent modified nucleotide 
positions on Denr cDNA). The cDNA was cloned directionally into the EcoRI site of 
pCIG-F vector by conventional ligase-dependent cloning. The construct was verified 
by sequencing before an endolow midiprep was prepared for cell transfection 
experiments and in utero electroporation. In utero electroporation was peformed as 
described in Experimental Procedures. Immunostaining was performed using the 
following primary antibodies: rabbit anti-phosphorylated Histone-H3(ser10) (06-570, 
Merck Millipore, 1:1000), rabbit anti-Pax6 (PRB-278P, Covance, 1:500) and rabbit 
anti-Tbr2 (ab23345, Abcam, 1:500). Species-appropriate Alexa Fluor (Molecular 
Probes) secondary antibodies were used for immunofluorescence detection. 
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